MarketsandMarkets: U.S. Biopharmaceuticals Market Worth $144 billion by 2016
BIOPHARMA analyzes the U.S. Biopharmaceuticals Market and its growth factors, with special emphasis on the top companies in the field and their product pipeline. The report also analyses the current trends and focus of the U.S. biopharmaceutical market and the challenges faced by the industry. It also provides profiles of the major companies participating in
MarketsandMarkets: U.S. Biopharmaceuticals Market Worth $144 billion by 2016 Read More »